New Three-Drug Combination Could Help Women with Aggressive Breast Cancer Live Longer, Study Suggests

After recovering, focus must be on exercise, diet and checkups: Doc

Panaji: A balanced diet, coupled with regular exercise, medical checkups, and good stress management are essential to keep cancer survivors in good he.

New three-drug combination could help women with aggressive breast cancer live longer, study suggests

The lead author said the study also showed the inavolisib-based therapy "more than doubled the time before their cancer progressed or worsened".

‘Breakthrough’ breast cancer therapy can slow advance of disease and prolong survival

Study shows combination treatment for aggressive breast cancer delays advance by average 17 months and chemotherapy by two yearsA new triple therapy for aggressive, advanced breast cancer slows the progression of the disease, delays the need for further chemotherapy and helps patients live longer, research reveals.The combination treatment is made up of two targeted drugs: inavolisib and palbociclib, and the hormone therapy fulvestrant. It impro…

A new triple therapy for aggressive, advanced breast cancer delays the progression of the disease by 17.2 months on average, delays the need for further chemotherapy by 2 years and helps patients live longer.